Friday, May 29, 2020 – Recognizing Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype, Presented by Chris Garvey, NP, University of California San Francisco, Pulmonary Rehabilitation, San Francisco, CA. Registration: 12:00PM PDT. Promotional education program begins at 12:15 PM PDT.
Please join this educational presentation by Chris Garvey. She is a nurse practitioner who cares for patients with sleep disorders and pulmonary conditions. Under the supervision of a doctor, she provides assessments, orders diagnostic tests, interprets test results and makes treatment recommendations. Garvey's research interests include exercise and self-management for patients with chronic lung disease.
Garvey has authored chapters in the Lippincott Manual of Nursing Practice and has had her work published in several national professional journals. She is a former president of the California Thoracic Society. She has also served on many national and state committees, including as co-chair of the American Thoracic Society's pulmonary rehabilitation group. In addition, she has assisted with developing numerous international guidelines on helping patients with pulmonary conditions improve their functional abilities, symptoms and quality of life. Her awards include the Mary Burns Award from the California Society for Pulmonary Rehabilitation and a research scholarship from the American Lung Association in California.
Dial 877-407-6045 to join the audio.
Friday, May 8th, 2020 at 3:00 PM - 4:00 PM EDT – Join COPD Foundation for "Making Sense of Telehealth & Virtual Exercise Programs" webinar. A panel of medical experts will join us to answer these questions and more: Are you new to telehealth and virtual doctor visits? What information can you give your health care team to help them create the best plan forward for you? And let's talk about exercise programs - are virtual pulmonary rehab programs right for you? How do I get started with fitness if there isn't an in-person, formal program available right now?
The Current State of OFEV® (nintedanib) in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype
Thursday, May 7, 2020 – On behalf of Boehringer lngelheim, Beth Keene cordially invites you to attend a presentation on: The Current State of OFEV® (nintedanib) in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype. Presented by: Paul Noble, MD, Cedars Sinai Medical Center Los Angeles, CA.
Space is limited, so please respond promptly. RSVP on or before Monday, May 4, 2020 by emailing to email@example.com or by calling 1-877-925-9550.